{"id":101139,"date":"2026-05-29T11:34:18","date_gmt":"2026-05-29T06:04:18","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=101139"},"modified":"2026-05-29T11:34:20","modified_gmt":"2026-05-29T06:04:20","slug":"q-line-biotech-ipo-listing-today-29-may-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/q-line-biotech-ipo-listing-today-29-may-2026\/","title":{"rendered":"Q-Line Biotech IPO Listing Today 29 May 2026: Opens at Rs 445 on NSE SME &#8211; 29.7% Gain Over Issue Price Rs 343, GMP Nailed Exactly"},"content":{"rendered":"<p><em>Q-Line Biotech IPO listing today (29 May 2026): opened at Rs 445 on NSE SME &#8211; exactly matching the GMP-implied price. +29.7% gain (Rs 102) over issue price Rs 343. Subscribed 987%. India&#8217;s largest SME IPO of 2026 delivers for allottees.<\/em><\/p><p><strong>The <a href=\"https:\/\/univest.in\/user\/stocks\/qline\/q-share-price-today\">Q-Line Biotech<\/a> IPO listing<\/strong> today (29 May 2026) delivered exactly what the grey market predicted. The stock opened at Rs 445 on NSE SME &#8211; a gain of Rs 102 or 29.7 percent over the issue price of Rs 343. The pre-listing GMP of Rs 102 implied an expected listing at Rs 445, and the Q-Line Biotech IPO listing hit that level precisely on opening. India&#8217;s largest SME IPO of 2026 by issue size at Rs 214.48 crore has rewarded its 987 percent subscribed investor base. Allottees who received shares at Rs 343 have a Rs 102 per share gain from Day 1.<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/q-line-biotech-ipo-listing-today-29-may-2026\/#Q-Line_Biotech_IPO_Listing_Key_Numbers\" title=\"Q-Line Biotech IPO Listing: Key Numbers\">Q-Line Biotech IPO Listing: Key Numbers<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/q-line-biotech-ipo-listing-today-29-may-2026\/#About_Q-Line_Biotech_IVD_Diagnostics_from_Lucknow\" title=\"About Q-Line Biotech: IVD Diagnostics from Lucknow\">About Q-Line Biotech: IVD Diagnostics from Lucknow<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/q-line-biotech-ipo-listing-today-29-may-2026\/#Should_Allottees_Hold_or_Book_Profit_at_Rs_445\" title=\"Should Allottees Hold or Book Profit at Rs 445?\">Should Allottees Hold or Book Profit at Rs 445?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/q-line-biotech-ipo-listing-today-29-may-2026\/#FAQs_on_Q-Line_Biotech_IPO_Listing\" title=\"FAQs on Q-Line Biotech IPO Listing\">FAQs on Q-Line Biotech IPO Listing<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/q-line-biotech-ipo-listing-today-29-may-2026\/#What_is_Q-Line_Biotech_IPO_listing_price_today\" title=\"What is Q-Line Biotech IPO listing price today?\">What is Q-Line Biotech IPO listing price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/q-line-biotech-ipo-listing-today-29-may-2026\/#What_is_Q-Line_Biotechs_gain_for_allottees\" title=\"What is Q-Line Biotech&#8217;s gain for allottees?\">What is Q-Line Biotech&#8217;s gain for allottees?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q-Line_Biotech_IPO_Listing_Key_Numbers\"><\/span><strong>Q-Line Biotech IPO Listing: Key Numbers<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><ul class=\"wp-block-list\"><li><strong>Listing Price: <\/strong>Rs 445 on NSE SME (29 May 2026)<\/li>\n\n<li><strong>Issue Price: <\/strong>Rs 343 per share (upper band)<\/li>\n\n<li><strong>Listing Gain: <\/strong>Rs 102 per share (+29.7% over issue price)<\/li>\n\n<li><strong>GMP vs Actual: <\/strong>GMP was Rs 102 &#8211; actual listing Rs 445 &#8211; perfect match<\/li>\n\n<li><strong>Subscription: <\/strong>987% overall | QIB 519% | NII 1,095% | Retail 1,007%<\/li>\n\n<li><strong>Issue Size: <\/strong>Rs 214.48 crore (India&#8217;s largest SME IPO of 2026)<\/li>\n\n<li><strong>Minimum allotment value at listing: <\/strong>800 shares \u00d7 Rs 445 = Rs 3,56,000 (applied at Rs 2,74,400 &#8211; gain Rs 81,600 per lot)<\/li>\n\n<li><strong>Pre-IPO anchor: <\/strong>Vikas Vijaykumar Khemani &#8211; Rs 14.94 crore at Rs 343 &#8211; thesis validated on Day 1<\/li><\/ul><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"About_Q-Line_Biotech_IVD_Diagnostics_from_Lucknow\"><\/span><strong>About Q-Line Biotech: IVD Diagnostics from Lucknow<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Q-Line Biotech Limited, founded in 2013 in Lucknow, Uttar Pradesh, manufactures and supplies In-Vitro Diagnostics (IVD) products &#8211; reagents, rapid test kits, haematology instruments, diagnostic equipment and pathology instruments. The company serves 150-plus national and international clients. FY25 revenue was Rs 322.58 crore (+56.2% from Rs 206.45 crore in FY24). The Q-Line Biotech IPO listing gain validates investor confidence in the IVD sector thesis &#8211; India&#8217;s organised diagnostics market is growing at 12-15 percent annually as hospital and lab infrastructure expands.<\/p><ul class=\"wp-block-list\"><li><strong>FY25 Revenue: <\/strong>Rs 322.58 crore (+56.2% YoY)<\/li>\n\n<li><strong>FY25 PAT: <\/strong>Rs 28.13 crore (vs Rs 34.44 crore in FY24 &#8211; PAT declined due to expansion investments)<\/li>\n\n<li><strong>Products: <\/strong>IVD reagents, rapid test kits, haematology instruments, point-of-care devices<\/li>\n\n<li><strong>IPO use: <\/strong>Rs 93.50 crore working capital + Rs 90 crore debt repayment + general corporate<\/li><\/ul><p><a href=\"https:\/\/univest.in\/login\"><strong>Tap to Access Best Research Pieces on Univest<\/strong><\/a><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Should_Allottees_Hold_or_Book_Profit_at_Rs_445\"><\/span><strong>Should Allottees Hold or Book Profit at Rs 445?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>The Q-Line Biotech IPO listing at Rs 445 &#8211; exactly at the GMP-implied price &#8211; creates the classic post-listing decision. At Rs 445, the implied market cap is approximately Rs 1,039 crore. FY25 revenue of Rs 322.58 crore at Rs 1,039 crore market cap implies a Price-to-Sales of approximately 3.2 times &#8211; reasonable for a diagnostics manufacturer with 56 percent revenue growth. The PAT decline in FY25 (from Rs 34.44 crore to Rs 28.13 crore) due to expansion investments is a watch item &#8211; FY26 PAT recovery will be the key trigger for secondary market performance.<\/p><p>For allottees who applied purely for listing gain: a 29.7 percent gain at opening is a strong outcome for a 5-day blocked capital period. Booking partial profits at Rs 445 and holding the balance for a medium-term target above Rs 500 is a balanced approach. NSE SME stocks can be illiquid in secondary markets &#8211; the market maker&#8217;s two-sided quote typically supports pricing only up to a limited daily volume. Consult a SEBI-registered advisor before any post-listing trading decision.<\/p><p>Disclaimer: This article is for informational and educational purposes only. Nothing in this article constitutes investment advice, a recommendation to buy or sell securities, or a solicitation of any offer to buy or sell securities. Univest is a SEBI-registered research analyst (INH000014019). Readers should conduct their own research and consult a SEBI-registered investment advisor before making any investment decisions. Past performance of any stock or sector is not indicative of future results. Investments in equity markets are subject to market risks<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"FAQs_on_Q-Line_Biotech_IPO_Listing\"><\/span><strong>FAQs on Q-Line Biotech IPO Listing<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_is_Q-Line_Biotech_IPO_listing_price_today\"><\/span><strong>What is Q-Line Biotech IPO listing price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p><strong>Ans. <\/strong>Q-Line Biotech IPO listing price today (29 May 2026) is Rs 445 on NSE SME &#8211; a gain of Rs 102 or 29.7% over the issue price of Rs 343. The pre-listing GMP of Rs 102 was exactly matched at listing. The IPO was subscribed 987% with Vikas Khemani as pre-IPO anchor at Rs 343.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_is_Q-Line_Biotechs_gain_for_allottees\"><\/span><strong>What is Q-Line Biotech&#8217;s gain for allottees?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p><strong>Ans. <\/strong>Allottees who received Q-Line Biotech shares at Rs 343 have a gain of Rs 102 per share (29.7%) at the listing price of Rs 445. For the minimum lot of 800 shares (applied at Rs 2,74,400), the value at listing is Rs 3,56,000 &#8211; a gain of Rs 81,600 per lot on Day 1.<\/p><p><\/p><p><\/p>","protected":false},"excerpt":{"rendered":"<p>Q-Line Biotech IPO listing today (29 May 2026): opened at Rs 445 on NSE SME &#8211; exactly matching the GMP-implied price. +29.7% gain (Rs 102) over issue price Rs 343. Subscribed 987%. India&#8217;s largest SME IPO of 2026 delivers for allottees. The Q-Line Biotech IPO listing today (29 May 2026) delivered exactly what the grey<\/p>\n","protected":false},"author":35,"featured_media":101150,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1281],"tags":[4230],"class_list":["post-101139","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo","tag-ipo-listing-today"],"metadata":{"_edit_lock":["1780034670:23"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"rank_math_primary_category":["1281"],"rank_math_seo_score":["78"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"rank_math_title":["Q-Line Biotech IPO Listing Today 29 May 2026: Lists at Rs 445, +29.7% "],"rank_math_description":["Q-Line Biotech IPO listing today 29 May 2026: opened at Rs 445, a gain of Rs 102 or 29.7% over issue price Rs 343 on NSE SME. India's largest SME IPO of 2026 subscribed 987%. "],"rank_math_focus_keyword":["Q-Line Biotech IPO"],"_thumbnail_id":["101150"],"_edit_last":["23"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["14229"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/05\/Q-Line-Biotech-IPO.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/101139","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=101139"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/101139\/revisions"}],"predecessor-version":[{"id":101152,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/101139\/revisions\/101152"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/101150"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=101139"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=101139"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=101139"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}